A Phase 1, Placebo-Controlled, Randomized, Parallel Group, Subject- And Investigator-Blind, Sponsor-Open Study To Assess The Safety, Tolerability, And Pharmacokinetics Of PH-797804 Following Multiple Escalating Oral Doses In Healthy Japanese Adult Subjects.

Trial Profile

A Phase 1, Placebo-Controlled, Randomized, Parallel Group, Subject- And Investigator-Blind, Sponsor-Open Study To Assess The Safety, Tolerability, And Pharmacokinetics Of PH-797804 Following Multiple Escalating Oral Doses In Healthy Japanese Adult Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 14 Feb 2011

At a glance

  • Drugs PH 797804 (Primary)
  • Indications Chronic obstructive pulmonary disease; Musculoskeletal pain; Neuropathic pain; Rheumatoid arthritis
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 14 Feb 2011 Actual end date (Feb 2011) added as reported by ClinicalTrials.gov.
    • 14 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 18 Jan 2011 Planned End Date changed from 1 Feb 2011 to 1 Jan 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top